Medicine
Almotriptan 12.5 mg tablet
Almotriptan 12.5 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted from 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Almotriptan
- Brand
- Sold under the generic name
- Strength
- 12.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 2 blister pack, 12 blister pack
- Manufacturers
- Ajanta PharmaIndiaMylan PharmaceuticalsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted from 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02CC05 Almotriptan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 July 2015
- Identifiers
- RxCUI 284204, 284205DailyMed set ID 6fa380c4-c885-4743-85bf-88819ae68645, 35617039-9f33-401b-bac3-8f85c65fa2c7, c41a4579-9db0-402b-81b1-0adf5b3978c3NDC 27241-042, 0378-5246, 0093-5261Application ANDA205523, ANDA205171, ANDA078027
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 27241-042-21 | Ajanta PharmaIndia | 7 October 2015 |
| 2 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 0378-5246-85 | Mylan Pharmaceuticals | 10 November 2015 |
| 12 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0093-5261-29 | Teva Pharmaceuticals | 7 July 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 May 2001 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Almotriptan
Clinical summary
Almotriptan is a serotonin-1b and serotonin-1d receptor agonist indicated for acute treatment of migraine attacks in adults with a history of migraine with or without aura, among other approved uses. MedsAcross supplies Almotriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AlmotriptanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- almotriptan prescribing information (Ajanta Pharma) · U.S. National Library of Medicine, DailyMed
Need Almotriptan 12.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.